The Accelerating Clinical Trials in the EU (ACT EU) initiative has taken a significant step forward with the launch of two new advice pilots aimed at enhancing the quality of clinical trial applications. These pilots are pivotal for advancing the development of safe and effective medicines across Europe. ACT EU is a joint effort by […]

The biopharmaceutical industry is constantly evolving, and with it, regulatory standards are adapting to ensure the highest safety and efficacy for new biologics and drug products. A critical component of this regulatory landscape is the Bioresearch Monitoring (BIMO) inspections conducted by the Center for Biologics Evaluation and Research (CBER). Recently, the FDA issued a draft

Developing innovative medical devices holds immense potential for improving patient care. But before your creation hits the market, it needs to undergo rigorous testing to ensure safety and efficacy. This is where the Medicines and Healthcare products Regulatory Agency (MHRA) comes in. Why Notify the MHRA? The MHRA plays a crucial role in safeguarding public

Foreign companies operating in the lifesciences industry often face complex regulatory requirements when entering the United States market. One crucial aspect of compliance is the appointment of a US Agent. In this blog post, we will delve into the significance of US Agent services for life sciences companies and how they facilitate effective communication and